anti-Zika virus IgM ELISA kit (μ-capture)
Be the first to review this product! Submit a review
|
(12 Publications)
- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
Reactivity data
Product details
Zika virus IgM ELISA (Enzyme-Linked Immunosorbent Assay) kit detects IgM antibodies specific to Zika virus in human serum and plasma. ELISA protocols are available in Spanish and English.
Microplates are coated with anti-human IgM-class antibodies to bind the corresponding antibodies of the sample. After washing the wells to remove all unbound sample material, horseradish peroxidase (HRP) labelled Zika virus antigen is added. This antigen-conjugate binds to the captured specific IgM antibodies. In a second washing step unbound conjugate is removed. The immune complex formed by the bound conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a blue reaction product.
The intensity of this product is proportional to the amount of specific IgM antibodies in the specimen. Sulphuric acid is added to stop the reaction. This produces a yellow endpoint colour.
Absorbance at 450/620 nm is read using an ELISA microwell plate reader.
Zika virus (ZIKV) is a single-stranded RNA virus of the Flaviviridae family (genus Flavivirus). It was first isolated in 1947 from a sentinel rhesus monkey during a yellow fever study in the Zika forest of Uganda.
Precision
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IgM acts as the first line of defense during the initial stages of an immune response. It plays an important part in agglutination and neutralization of pathogens forming a complex that alerts other components of the immune system to take action. IgM exists before class-switching to IgG providing immediate protection. It also plays a role in antibody-dependent cellular cytotoxicity. Although not typically a long-term solution its presence is critical for providing initial protection until more specific antibodies like IgG and IgA are produced.
Pathways
The immune response that involves IgM begins with the activation of the classical complement pathway. This pathway bridges the innate and adaptive immunity ensuring the communication and coordination of immune responses. The pathway involves C1q protein binding to IgM-antigen complexes. IgM also interacts with antigen-presenting cells facilitating the processing of antigens and interaction with T cells. These interactions connect IgM with other proteins like IgG and IgA influencing various immune response pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
Journal of medical virology 97:e70384 PubMed40400258
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 19:e1011282 PubMed36976812
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 18:e1010386 PubMed35969617
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS neglected tropical diseases 16:e0010623 PubMed35926066
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:703887 PubMed34367162
2021
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 15:e0235877 PubMed33091010
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 94: PubMed32188737
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 94: PubMed31597777
2019
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 15:e1007507 PubMed30657788
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 92: PubMed29875247
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com